EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy

BACKGROUND: Overexpression of the EVI1 (ecotropic viral integration site 1) oncogene has recently been implicated as a prognostic factor in breast cancer (BC), particularly in triple-negative BC (TNBC). In this study we aimed to investigate frequency and clinical relevance of EVI1 expression in newl...

Descripción completa

Detalles Bibliográficos
Autores principales: Leichsenring, Jonas, Vladimirova, Valentina, Solbach, Christine, Karn, Thomas, Ataseven, Beyhan, Sinn, Bruno Valentin, Barinoff, Jana, Müller, Volkmar, Blohmer, Jens-Uwe, Schem, Christian, Engels, Knut, Marmé, Frederik, Fisseler-Eckhoff, Annette, Fasching, Peter A., Stickeler, Elmar, van Mackelenbergh, Marion, Denkert, Carsten, Stenzinger, Albrecht, Loibl, Sibylle, Gröschel, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533588/
https://www.ncbi.nlm.nih.gov/pubmed/36195836
http://dx.doi.org/10.1186/s12885-022-10109-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533588/
https://www.ncbi.nlm.nih.gov/pubmed/36195836
http://dx.doi.org/10.1186/s12885-022-10109-1

Ejemplares similares